Notes
incremental cost effectiveness ratio
Reference
Sie AS, et al. Fourfold increased detection of Lynch syndrome by raising age limit for tumour genetic testing from 50 to 70 years is cost-effective. Annals of Oncology : 31 Jul 2014. Available from: URL: http://doi.org/10.1093/annonc/mdu361
Rights and permissions
About this article
Cite this article
Benefits of increasing age limit for Lynch syndrome genetic testing. PharmacoEcon Outcomes News 709, 3 (2014). https://doi.org/10.1007/s40274-014-1447-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1447-1